Neurocysticercosis: The duration of its preclinical phase relies on the parasite location

Carlos Alejandro Tellez‐Arellano,Jan Kuschick‐Fehér,Franco Gabriel Romero‐Gonzalez,Agnès Fleury
DOI: https://doi.org/10.1111/tmi.13964
2024-01-12
Tropical Medicine & International Health
Abstract:Objectives Neurocysticercosis (NC) is a heterogeneous disease particularly in terms of response to treatment and prognosis. Parasite localization is one of the main factors involved in this heterogeneity. In this study we aim to determine whether differences in the duration of the preclinical phase associated with parasite location, could contribute to said heterogeneity. Methods Ninety‐nine patients were included, 24 with parasites in the parenchyma (PAR), 56 in the subarachnoid (SA) space and 19 in the ventricular system (IV). A questionnaire designed to assess exposure to classic NC risk factors 5, 10, 15, 20 and more than 20 years prior to diagnosis was applied. The results were compared between the three groups. Also, asymptomatic relatives of patients who had shared their living conditions in childhood or more recently were included and underwent brain scan and blood testing for specific antibodies. Results Over the course of their lives, exposure to risk factors decreased significantly for all patients, although the decrease was more evident in patients with parasites in the SA space (p
public, environmental & occupational health,tropical medicine
What problem does this paper attempt to address?